Empirical Finance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
|
|||||
|
2025
Q1 | $4.34M | Buy |
|
|||||
|
2024
Q4 | $3.55M | Sell |
|
|||||
|
2024
Q3 | $4.15M | Buy |
|
|||||
|
2024
Q2 | $4.09M | Sell |
|
|||||
|
2024
Q1 | $3.9M | Buy |
|
|||||
|
2023
Q4 | $3.67M | Buy |
|
|||||
|
2023
Q3 | $3.12M | Buy |
|
|||||
|
2023
Q2 | $2.85M | Buy |
|
|||||
|
2023
Q1 | $2.26M | Buy |
|
|||||
|
2022
Q4 | $1.97M | Buy |
|
|||||
|
2022
Q3 | $1.82M | Buy |
|
|||||
|
2022
Q2 | $1.48M | Buy |
|
|||||
|
2022
Q1 | $1.3M | Buy |
|
|||||
|
2021
Q4 | $975K | Buy |
|
|||||
|
2021
Q3 | $592K | Buy |
|
|||||
|
2021
Q2 | $620K | Buy |
|
|||||
|
2021
Q1 | $626K | Hold |
|
|||||
|
2020
Q4 | $626K | Buy |
|
|||||
|
2020
Q3 | $594K | Buy |
|
|||||
|
2020
Q2 | $493K | Buy |
|
|||||
|
2020
Q1 | $353K | Buy |
|
|||||
|
2019
Q4 | $208K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $8K | Buy |
|